Context: Visceral (VAT) and subcutaneous adipose tissue (SAT) function as endocrine organs capable of influencing metabolic health across adiposity levels. Objective: To investigate whether metabolites associated with VAT and SAT impact metabolic health through metabolite concentrations. Methods: Analyses are based on 1790 participants from the population-based Rhineland Study. We assessed plasma levels of Methionine (Met), branched-chain amino acids (BCAA), aromatic amino acids (AAA), and their metabolic downstream metabolites with liquid chromatography-mass spectrometry. VAT and SAT volumes were assessed by magnetic resonance imaging (MRI). Metabolically healthy and unhealthy phenotypes were defined using Wildman criteria. Results: Metabolically unhealthy participants had higher concentrations of BCAA than metabolically healthy participants (p < 0.001). In metabolically unhealthy participants, VAT volumes were significantly associated with levels of L-Isoleucine, L-Leucine, indole-3-lactic acid, and indole-3-propionic acid (in log standard deviation units: β=0.16, p=0.003; β=0.12, p=0.038; β=0.11, p=0.035 and β= -0.16, p=0.010, respectively). Higher concentrations of certain BCAA and AAA-downstream metabolites significantly increased the odds of cardiometabolic risk markers. The relation between VAT volume and cardiometabolic risk markers was mediated by BCAA (indirect effects 3.7 to 11%, p=0.02 to <0.0001), while the effect of VAT on systemic inflammation was mediated through higher kynurenine concentrations (indirect effect 6.4%, p<0.0001). Conclusions: Larger volumes of VAT in metabolically unhealthy individuals are associated with altered concentrations of circulating BCAA and AAA-downstream metabolites, increasing the odds of cardiometabolic risk markers. This suggests that these metabolites are involved in the mechanisms that underlie the relationship of abdominal VAT with metabolic health.
Branched-chain and aromatic amino acids related to visceral adipose tissue impact metabolic health risk markers / Orozco-Ruiz, Ximena; Anesi, Andrea; Mattivi, Fulvio; Breteler, Monique M B. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. - ISSN 1945-7197. - 2022:(2022), pp. 1-10. [10.1210/clinem/dgac160]
Titolo: | Branched-chain and aromatic amino acids related to visceral adipose tissue impact metabolic health risk markers | |
Autori: | Orozco-Ruiz, Ximena; Anesi, Andrea; Mattivi, Fulvio; Breteler, Monique M B | |
Autori Unitn: | ||
Titolo del periodico: | THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | |
Anno di pubblicazione: | 2022 | |
Codice identificativo Pubmed: | 35325166 | |
Codice identificativo WOS: | WOS:000784507100001 | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1210/clinem/dgac160 | |
Handle: | http://hdl.handle.net/11572/337834 | |
Citazione: | Branched-chain and aromatic amino acids related to visceral adipose tissue impact metabolic health risk markers / Orozco-Ruiz, Ximena; Anesi, Andrea; Mattivi, Fulvio; Breteler, Monique M B. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. - ISSN 1945-7197. - 2022:(2022), pp. 1-10. [10.1210/clinem/dgac160] | |
Appare nelle tipologie: | 03.1 Articolo su rivista (Journal article) |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Orozco-Ruiz et al_dgac160.pdf | articolo principale, versione online non ancora impaginata | Post-print referato (Refereed author’s manuscript) | Tutti i diritti riservati (All rights reserved) | Embargo: 24/03/2023 |
dgac160.pdf | first online | Versione editoriale (Publisher’s layout) | Tutti i diritti riservati (All rights reserved) | Administrator |